Pfizer won its fight to buy an obesity-drug maker. It took an extra $1.7 billion and a phone call.
MarketWatch·2025-11-10 21:05Pfizer is buying its way back into the obesity-drug game after fighting off a rival bid from Novo Nordisk to buy Metsera, with more money and help from the Trump administration. ...